Skip to main content
. Author manuscript; available in PMC: 2010 Apr 8.
Published in final edited form as: Mol Cell Pharmacol. 2009 Aug 5;1(2):85–91. doi: 10.4255/mcpharmacol.09.10

Figure 4. Primary splenic tumors.

Figure 4

Splenic tumors of mice treated with Nef-M1 (N), Control (C), and scramble peptide (S) bi-weekly for one month following spleens inoculation with CRC cells. Pictures were taken using a Kodak DC290 zoom digital camera.